Additional information

Prescription drugs
Drug shortages
One hand holding a pen and the other hand flipping through a report
Prescription drugs: CSAPH reports
Pharmacists
COVID-19 policy recommendations for OUD, pain, harm reduction
Clear Search
UPDATED
·
5 MIN READ

COVID-19 policy recommendations for OUD, pain, harm reduction

Download guidance and issue brief PDFs—the AMA provides policy recommendations to help guide policymakers to reduce the stress of patients with an opioid use disorder and pain during the COVID-19 outbreak.

series
Public Health
AMA COVID-19 Guides
·
3 MIN READ

Nov. 20, 2020: Advocacy Update spotlight on Highlights from the November 2020 AMA Special Meeting

Highlights from the November 2020 AMA Special Meeting in the latest Advocacy Update spotlight.

Advocacy Update
Scale in medical office
·
3 MIN READ

COVID-19 exacerbates drug shortages. AMA details next steps.

Analgesics, sedatives among drugs affected by the pandemic. Delegates urge improvements to the global pharmaceutical product supply chain.

Public Health
·
3 MIN READ

AMA strengthens policy to combat spike in national drug shortages

Policy outlines a comprehensive framework to address ongoing drug shortages, which have been exacerbated during the COVID-19 pandemic.

Press Releases
·
4 MIN READ

Top news stories from AMA Morning Rounds®: Week of Aug. 3, 2020

In the news: Young adults with COVID-19 may take weeks to recover, review finds U.S. vaccines are safe and more.

Publications & Newsletters
·
4 MIN READ

Top news stories from AMA Morning Rounds®: Week of May 25 - 29, 2020

The news: 80 mill. babies missing vaccines, CDC guidance on antibody tests, study on asymptomatic COVID-19 patients, prescription drug supply, Dr. Harris op-ed

Publications & Newsletters
Prescription drugs
·
4 MIN READ

COVID-19 casts new light on an old problem: Drug shortages

National drug shortages are chronic. Learn about the root causes and efforts to these shortages, both in the long term and during the pandemic.

Public Health
UPDATED
·
4 MIN READ

Joint statement on ordering, prescribing or dispensing COVID-19 medications

Organizations highlight role physicians, pharmacists and health systems play in being just stewards of health care resources during times of emergency.

Public Health
·
1 MIN READ

AMA praises DEA allowing increase in controlled substance production

During COVID-19, the number of patients requiring ventilators has resulted in huge spikes in demand for controlled substances.

Press Releases